NASDAQ:YDES YD Bio Q2 2026 Earnings Results & Report $6.73 +0.94 (+16.23%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$6.82 +0.09 (+1.34%) As of 10/9/2026 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. YD Bio reported Q2 2026 earnings on September 1, 2026. The company reported EPS of $0.05, while revenue was $0.42 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateSeptember 1, 2026TimeAfter Market Closes YD Bio EPS ResultsActual EPS$0.05Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AYD Bio Revenue ResultsActual Revenue$0.42 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile YD Bio Q2 2026 Earnings FAQ Did YD Bio beat earnings estimates for Q2 2026? YD Bio (NASDAQ:YDES) reported earnings of $0.05 per share for Q2 2026. The report was announced on Tuesday, September 1, 2026. What was YD Bio's revenue for Q2 2026? YD Bio reported revenue of $0.42 million for Q2 2026. YD Bio Earnings HeadlinesYD Bio and EG BioMed Launch AI-Based 10-Cancer Risk Factor AssessmentOctober 6, 2026 | globenewswire.comYD Bio Ltd (YDES)September 1, 2026 | finance.yahoo.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)YD Bio Files First-Half 2026 Results, Reports Improved Equity PositionSeptember 1, 2026 | tipranks.comYD Bio Limited Reports First-Half 2026 Financial Results, 315% Revenue Growth and Net Income of $6.7 MillionAugust 31, 2026 | quiverquant.comQYD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026August 31, 2026 | globenewswire.comSee More YD Bio Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like YD Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on YD Bio and other key companies, straight to your email. Email Address About YD BioYD Bio (NASDAQ:YDES) is a biotechnology company focused on the development of DNA methylation-based cancer detection technologies and ophthalmologic innovations. The company also provides clinical trial support and related research services. YD Bio Limited is headquartered in Taipei, Taiwan, and its ordinary shares trade on the Nasdaq Global Market under the ticker symbol YDES.View YD Bio ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
